Department of Diagnostic Pathology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.
Pathol Int. 2024 May;74(5):285-291. doi: 10.1111/pin.13424. Epub 2024 Apr 2.
We herein report a case of methotrexate-associated lymphoproliferative disorder (MTX-LPD) showing fibrin-associated large B-cell lymphoma-like heart valve lesions, and Epstein-Barr virus (EBV)-positive mucocutaneous ulcer-like cutaneous and oral mucosal lesions. MTX-LPD is a critical complication that can occur in RA patients who are treated with MTX. EBV also plays a defining or important role in LPDs. Among the sites of MTX-LPD, 40-50% occur in extranodal sites, including the gastrointestinal tract, skin, liver, lung, and kidney. There are few reports of MTX-LPDs involving the heart valves, and to the best of our knowledge, this is the first case to be reported in the English literature. The possibility of EBV-positive LPD should be considered in RA patients, even in patients with an atypical site, as in this case.
我们在此报告一例甲氨蝶呤相关性淋巴增生性疾病(MTX-LPD),其表现为纤维蛋白相关的大 B 细胞淋巴瘤样心脏瓣膜病变,以及 EBV 阳性的黏膜溃疡性皮肤和口腔黏膜病变。MTX-LPD 是一种严重的并发症,可能发生在接受 MTX 治疗的 RA 患者中。EBV 在 LPD 中也起着决定性或重要作用。在 MTX-LPD 的部位中,40-50%发生在结外部位,包括胃肠道、皮肤、肝脏、肺和肾脏。涉及心脏瓣膜的 MTX-LPD 很少见,据我们所知,这是首例在英文文献中报道的病例。即使在这种情况下,对于 RA 患者,即使在非典型部位,也应考虑 EBV 阳性 LPD 的可能性。